Conferences and symposiums Young Researchers in Hematology Symposium
The FoU committee PO Hematology KI/K welcomes researchers working in Hematology to the 2nd "Young researchers in Hematology Symposium" on May 4, 2022.
The speakers consist only of younger researchers (PhD students, post docs, and young group leaders) from Stockholm and all talks/pitches are appointed in advance.
We hope for great attendance and networking!
Mattias Carlsten, Marzia Palma, Bianca Tesi, Johan Törlén, Johanna Ungerstedt on behalf of the FoUU committee ME Hematology KI/K
Gunilla Enblad: CAR T-cells: the immunotherapy of the future
Sara Harrysson: Population-based studies of diffuse large B-cell lymphomas
Katarina Holmberg: Nursing and personalized patient care in allogeneic stem cell transplantation.
Maria Creignou: Combined transfusion and molecular patterns as dynamic predictors of outcomes in patients with MDS
Fatemah Rezayee: Refining genetic stratification in childhood acute lymphoblastic leukemia - is wgs the answer?
Madeleine Leander: Immune targeting of a neo-antigen in primary human acute myeloid leukemia
Maria Andersson: Incidence of cardiovascular and bleeding events in CLL patients treated with ibrutinib.
Natali Karandyszowska: Diagnostic and therapeutic challenges in patients with antiphospholid syndrome.
Ioanna Xagoraris: The cGAS-STING anti-tumor immune response pathway in anaplastic large cell lymphoma.
Ebba Sohlberg / Andreas Björklund: ADAPT-NK - An ”off-the-shelf” NK cell therapy against chemotherapy-refractory AML and MDS.
Roland Fiskesund: Neutrophil transfusion to neutropenic patients with antibiotic resistant infections.
Pedro Moura: Integrative analysis of primary SF3B1mt ring sideroblasts provides fundamental insights into MDS-RS pathogenesis.
Joakim Dahlin: Charting mast cell differentiation at the single-cell level in health and disease.
Ayla Da Paepe: Career service for PhD students and post docs.
Gustaf Edgren: Statistics and epidemiology.
Fulya Taylan: Massive parallel sequencing in hemato-oncology research
Jeffrey Yachnin: Clinical trial design for dummies.
Laura Covill: Genetic pre-disposition to covid-19
Lisa Blixt: Clinical and immunological outcome in patients with CLL after Covid19 infection and/or vaccination.
Gustaf Ekelin Lindgren: Immunogenicity and safety of the mRNA BNT162b2 vaccine against SARS-CoV-2 in allogenic stem cell transplantation and CAR T cell patients.
Maria Karvouni: Increasing the feasibility of αCD38-CAR-NK therapy by harnessing features of cytokine-expanded NK cells
Caroline Palm Apergi: RNAi prodrugs against pediatric leukemia.
Nicolai Frengen: The role of E proteins in hematopoesis Christopher Melén. Cannabinoids and indolent lymphomas.
Marie Meeths: Title to be announced